Viatris (VTRS) Current Taxes (2019 - 2025)
Viatris' (VTRS) quarterly Current Taxes came in at $124.0 million in Q4 2025, down 35.65% year-on-year from $192.7 million in Q4 2024, and up 32.76% quarter-over-quarter from $93.4 million in Q1 2025.
Viatris (VTRS) Current Taxes (2019 - 2025) Analysis & Trends
Viatris' Current Taxes history runs 7 years deep, the most recent figure standing at $124.0 million for Q4 2025.
- On a quarterly basis, Current Taxes fell 35.65% year-over-year to $124.0 million in Q4 2025; TTM through Dec 2025 was $124.0 million, a 35.65% decrease from a year earlier, with the FY2025 full-year figure at $124.0 million, down 35.65% from the prior year.
- Current Taxes improved to $124.0 million in Q4 2025 per VTRS's latest filing, from $93.4 million in the prior quarter.
- Across five years, Current Taxes topped out at $752.0 million in Q1 2021 and bottomed at $93.4 million in Q1 2025.
- The 5-year median for Current Taxes is $195.4 million (2021), against an average of $239.4 million.
- Across the five-year window, Current Taxes plunged 80.24% in 2022 and jumped 93.91% in 2023, its largest moves.
- Year by year, Current Taxes stood at $236.9 million in 2021, then increased by 18.02% to $279.6 million in 2022, then slipped by 18.88% to $226.8 million in 2023, then retreated by 15.04% to $192.7 million in 2024, then sank by 35.65% to $124.0 million in 2025.
- Per Business Quant, the three latest VTRS Current Taxes figures stand at $124.0 million (Q4 2025), $93.4 million (Q1 2025), and $192.7 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 124.00 Mn |
| Mar 31, 2025 | 93.40 Mn |
| Dec 31, 2024 | 192.70 Mn |
| Sep 30, 2024 | 284.10 Mn |
| Jun 30, 2024 | 117.70 Mn |
| Mar 31, 2024 | 148.40 Mn |
| Dec 31, 2023 | 226.80 Mn |
| Sep 30, 2023 | 206.90 Mn |
| Jun 30, 2023 | 158.10 Mn |
| Mar 31, 2023 | 244.50 Mn |
| Dec 31, 2022 | 279.60 Mn |
| Sep 30, 2022 | 106.70 Mn |
| Jun 30, 2022 | 125.70 Mn |
| Mar 31, 2022 | 177.80 Mn |
| Dec 31, 2021 | 236.90 Mn |
| Sep 30, 2021 | 198.00 Mn |
| Jun 30, 2021 | 636.00 Mn |
| Mar 31, 2021 | 752.00 Mn |
| Dec 31, 2020 | 288.60 Mn |
| Dec 31, 2019 | 213.00 Mn |